ID

35750

Description

Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01867502

Link

https://clinicaltrials.gov/show/NCT01867502

Keywords

  1. 3/20/19 3/20/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 20, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 2 NCT01867502

Eligibility Diabetes Mellitus, Type 2 NCT01867502

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
Description

Diabetes Mellitus, Non-Insulin-Dependent | Glucose measurement, fasting

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0202045
recent hba1c determination (between 7, 5 and 10%);
Description

Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0474680
not involved in regular physical exercise;
Description

Absence Involvement with Exercise Regular

Data type

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0015259
UMLS CUI [1,4]
C0205272
older than 18 years;
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
in use of metformin.
Description

Metformin

Data type

boolean

Alias
UMLS CUI [1]
C0025598
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
smoker and use of analgesic or anti-inflammatory drugs during the week of the study
Description

Tobacco use | Analgesics | Anti-Inflammatory Agents

Data type

boolean

Alias
UMLS CUI [1]
C0543414
UMLS CUI [2]
C0002771
UMLS CUI [3]
C0003209
bmi > 40 kg/m²;
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
proliferative retinopathy;
Description

Proliferative retinopathy

Data type

boolean

Alias
UMLS CUI [1]
C0339467
ischemic cardiomyopathy;
Description

Ischemic cardiomyopathy

Data type

boolean

Alias
UMLS CUI [1]
C0349782
peripheral vascular disease;
Description

Peripheral Vascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0085096
blood aspartate transaminase (ast) and alanine transaminase (alt) 2.5 times higher the normal concentration before screening visit
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
lactose intolerance;
Description

Lactose Intolerance

Data type

boolean

Alias
UMLS CUI [1]
C0022951
renal insufficiency (creatinine clearance <60ml/min);
Description

Renal Insufficiency | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0373595
blood pressure more than 180/100mmhg at rest (3 consecutive measures).
Description

Blood pressure determination At rest | Measurement Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0005824
UMLS CUI [1,2]
C0443144
UMLS CUI [2,1]
C0242485
UMLS CUI [2,2]
C1265611

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01867502

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Glucose measurement, fasting
Item
type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
boolean
C0011860 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
Hemoglobin A1c measurement
Item
recent hba1c determination (between 7, 5 and 10%);
boolean
C0474680 (UMLS CUI [1])
Absence Involvement with Exercise Regular
Item
not involved in regular physical exercise;
boolean
C0332197 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0015259 (UMLS CUI [1,3])
C0205272 (UMLS CUI [1,4])
Age
Item
older than 18 years;
boolean
C0001779 (UMLS CUI [1])
Metformin
Item
in use of metformin.
boolean
C0025598 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Tobacco use | Analgesics | Anti-Inflammatory Agents
Item
smoker and use of analgesic or anti-inflammatory drugs during the week of the study
boolean
C0543414 (UMLS CUI [1])
C0002771 (UMLS CUI [2])
C0003209 (UMLS CUI [3])
Body mass index
Item
bmi > 40 kg/m²;
boolean
C1305855 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy;
boolean
C0339467 (UMLS CUI [1])
Ischemic cardiomyopathy
Item
ischemic cardiomyopathy;
boolean
C0349782 (UMLS CUI [1])
Peripheral Vascular Disease
Item
peripheral vascular disease;
boolean
C0085096 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
blood aspartate transaminase (ast) and alanine transaminase (alt) 2.5 times higher the normal concentration before screening visit
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Lactose Intolerance
Item
lactose intolerance;
boolean
C0022951 (UMLS CUI [1])
Renal Insufficiency | Creatinine clearance measurement
Item
renal insufficiency (creatinine clearance <60ml/min);
boolean
C1565489 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Blood pressure determination At rest | Measurement Quantity
Item
blood pressure more than 180/100mmhg at rest (3 consecutive measures).
boolean
C0005824 (UMLS CUI [1,1])
C0443144 (UMLS CUI [1,2])
C0242485 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial